Vanguard Personalized Indexing Management LLC Raises Holdings in Waters Corporation $WAT

Key Points

• Vanguard Personalized Indexing Management LLC increased its holdings in Waters Corporation by 16.9% during the second quarter, owning 9,477 shares valued at $3,308,000.
• Several large investors have also modified their positions in Waters, contributing to institutional investors owning 94.01% of the company's stock.
• Analyst ratings for Waters show a consensus of "Moderate Buy" with a price target averaging $377.56.

Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 16.9% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 9,477 shares of the medical instruments supplier's stock after acquiring an additional 1,368 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Waters were worth $3,308,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Olde Wealth Management LLC purchased a new stake in shares of Waters during the first quarter worth about $25,000. Zions Bancorporation National Association UT purchased a new stake in shares of Waters during the first quarter worth about $28,000. IFP Advisors Inc grew its stake in shares of Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after acquiring an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Waters during the first quarter worth about $41,000. Finally, Steph & Co. purchased a new stake in shares of Waters during the second quarter worth about $73,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Analyst Ratings Changes

WAT has been the topic of a number of recent research reports. Rothschild Redb upgraded Waters to a "strong-buy" rating in a research report on Wednesday, October 8th. Wells Fargo & Company dropped their target price on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a research report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 target price on Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the company a "hold" rating in a research report on Tuesday, August 5th. Finally, Scotiabank reiterated a "sector outperform" rating and issued a $465.00 target price on shares of Waters in a research report on Friday, July 11th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $377.56.

Waters Trading Down 0.9%

Shares of NYSE:WAT opened at $333.45 on Wednesday. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The company has a market capitalization of $19.85 billion, a PE ratio of 30.07, a PEG ratio of 3.14 and a beta of 1.04. The business has a 50 day moving average of $302.03 and a two-hundred day moving average of $323.46. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $608.55 million during the quarter. As a group, analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.